Page last updated: 2024-08-25

uk 68798 and Ventricular Dysfunction

uk 68798 has been researched along with Ventricular Dysfunction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gold, MR; Leman, RB; Simon, RD; Sturdivant, JL; Wharton, JM	1
Decara, JM; Falk, RH	1

Reviews

1 review(s) available for uk 68798 and Ventricular Dysfunction

Article	Year
Dofetilide: a new pure class III antiarrhythmic agent. American heart journal, 2000, Volume: 140, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Administration Schedule; Electrophysiology; Food-Drug Interactions; Heart Conduction System; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tachycardia; Ventricular Dysfunction	2000

Article

Year

Dofetilide: a new pure class III antiarrhythmic agent.

American heart journal, 2000, Volume: 140, Issue:5

Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Administration Schedule; Electrophysiology; Food-Drug Interactions; Heart Conduction System; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tachycardia; Ventricular Dysfunction

2000

Trials

1 trial(s) available for uk 68798 and Ventricular Dysfunction

Article	Year
The effect of dofetilide on ventricular defibrillation thresholds. Pacing and clinical electrophysiology : PACE, 2009, Volume: 32, Issue:1 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Treatment Outcome; Ventricular Dysfunction	2009